Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood test study aims to predict which cGVHD treatments will work

NCT ID NCT04431479

Summary

This study aims to help doctors predict how patients with chronic graft-versus-host disease (cGVHD) will respond to new treatments. Researchers will collect blood samples and survey data from 300 adult patients before and after they start new therapies. The goal is to identify patterns that might indicate whether a treatment will be effective for individual patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cleveland Clinic Foundation

    RECRUITING

    Cleveland, Ohio, 44195, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Dana-Farber Harvard Cancer Center

    RECRUITING

    Boston, Massachusetts, 02115, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Fred Hutch/University of Washington Cancer Consortium

    RECRUITING

    Seattle, Washington, 98109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Roswell Park Cancer Institute

    COMPLETED

    Buffalo, New York, 14263, United States

  • UPMC Hillman Cancer Center

    COMPLETED

    Pittsburgh, Pennsylvania, 15232, United States

  • University of Florida

    COMPLETED

    Gainesville, Florida, 32610, United States

  • University of Minnesota/Masonic Cancer Center

    COMPLETED

    Minneapolis, Minnesota, 55455, United States

  • Vancouver General Hospital/BC Cancer

    COMPLETED

    Vancouver, British Columbia, V5Z 4E6, Canada

  • Vanderbilt University/Ingram Cancer Center

    COMPLETED

    Nashville, Tennessee, 37232, United States

Conditions

Explore the condition pages connected to this study.